darglitazone has been researched along with ad 5075 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, J; Diaz, E; Hayes, N; Smith, R; Szalkowski, D; Zhang, B | 1 |
1 other study(ies) available for darglitazone and ad 5075
Article | Year |
---|---|
Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Muscles; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Pioglitazone; Protein-Tyrosine Kinases; Rats; Receptor, Insulin; Signal Transduction; Thiazoles; Thiazolidinediones | 1994 |